Paul Bisaro is Director of MYRIAD GENETICS INC. Currently has a direct ownership of 40,145 shares of MYGN, which is worth approximately $621,846. The most recent transaction as insider was on Jun 06, 2024, when has been sold 15,695 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 40.1K
0% 3M change
64.19% 12M change
Total Value Held $621,846

PAUL BISARO Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
15,695 Added 28.11%
40,145 Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
7,575 Added 23.65%
24,450 Common Stock
Oct 31 2022
BUY
Grant, award, or other acquisition
-
16,875 Added 50.0%
16,875 Common Stock

Also insider at

ZTS
Zoetis Inc. Healthcare
TXMD
TherapeuticsMD, Inc. Healthcare
MNKPF
Mallinckrodt plc Healthcare
PB

Paul Bisaro

Director
Hazelwood, MO

Track Institutional and Insider Activities on MYGN

Follow MYRIAD GENETICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MYGN shares.

Notify only if

Insider Trading

Get notified when an Myriad Genetics Inc insider buys or sells MYGN shares.

Notify only if

News

Receive news related to MYRIAD GENETICS INC

Track Activities on MYGN